Hong Kong stock market anomaly | Fosun Pharma (03933.HK) rose nearly 4%, planning to spend up to HK$200 million to repurchase shares TUL321 capsules obtained implied approval for clinical trials of new drugs in China
According to CITIC Securities Finance APP, Sinopharm Group (03933.HK) rose nearly 4%, up 3.91% as of press time, to 8.76 Hong Kong dollars, with a turnover of 68.7594 million Hong Kong dollars.
Latest
